Swiss Space Systems, SpacePharma to Develop Life Science Communications System

Swiss_Space_Systems_logoKENNEDY SPACE CENTER, Fla., September 2, 2014 (S3 & SpacePharma PR) — S3 USA Operations (Florida), Inc., a division of Swiss aerospace company Swiss Space Systems – S3, and SpacePharma R&D Lts (Israel) a fully owned subsidiary of Swiss SpacePharma SA, which specializes in solutions for medical experiments in microgravity, announce today having been selected as winners in a prize awarded by Space Florida in the Space Florida-Israel Innovation Partnership RFP for the development of a pioneering 2-way communications platform. This platform enables live data transfer between microgravity experiments onboard a Zero Gravity aircraft and a ground station.